Relentless Health Value

Paul Pochtar is an industry leader who has more than 25 years of extensive experience leading the successful commercialization of specialty pharmaceuticals throughout their lifecycle, including several landmark oncology products and other specialty therapeutics. He has been instrumental in developing innovative brand value propositions that resonate with government and commercial payers and in the execution of market introductions by designing novel distribution, dispensing, and patient services models. He has strong operational proficiency and a keen ability to mobilize both Pharma functional skill centers and channel partners to build plans, structures, and processes to efficiently execute strategies. Paul has enjoyed a distinguished career with Bayer Pharmaceuticals as Vice President of Payer Marketing and with Novartis Pharmaceuticals as Vice President & Head of Oncology Managed Markets and Market Access. He is a graduate of Rutgers University Ernest Mario College of Pharmacy and is a registered pharmacist in New Jersey and Pennsylvania. He can be reached at paulpochtar@gmail.com

Over the course of a 20-year career, Trevor has started, built, shut down, funded, bought and sold technology and service companies, largely in the healthcare industry as an entrepreneur, investor and executive search consultant. In this current chapter of his entrepreneurial/A.D.D.-fueled professional career, Trevor serves as the Chairman of Oxeon Holdings, a healthcare growth services firm that connects our healthcare company partners with the fundamental drivers of business growth: great people, transformational business development partnerships, strategic investments, next generation business ideas and other growth-related services. On a day-to-day basis, Trevor leads Oxeon Partners, an Invested Executive Search firm that finds the right leaders to drive growth for healthcare technology and service companies. The firm invests in our clients, both emotionally and financially, and aligns itself with the long-term growth and success of the companies we work with. Trevor has overseen leadership team development across the C-Suite with many of Oxeon's clients including Evolent Health, athenahealth, The Advisory Board Company, Health Catalyst, HealthGrades, Imagine Health, Clover Health, Grand Rounds, Accolade, Pager, GoHealth, Brighton Health, Landmark Health, Avalon, Omada, Sutter Health, Intermountain and others. Along with leading Oxeon's invested executive search firm, Trevor also serves as the Managing General Partner of Oxeon Investments I LLC and Oxeon Investments II LLC, which provide strategic growth capital to venture-capital and private equity-backed healthcare technology and service companies. Finally, Trevor is the Founder and on the Board of Directors and Investment Committee of Cien Ventures, a venture studio that leverages Oxeon Partners' network of relationships to conceive and start healthcare technology and service companies. Trevor currently sits on the Board of Directors of CureSearch for Pediatric Cancer, Friends of Hudson River Park Trust, Patient Steward, Dossier Health and also serves on Advisory Boards for numerous other companies. Prior to starting Oxeon Partners, Trevor's career was wide-ranging – see above re: entrepreneurial/A.D.D. – as a co-founder of a number of start-up technology and service companies where he served as a CEO, Managing Partner, President & COO, as well as, VP of Marketing, Strategy, Sales and/or Business Development. His companies have been funded by leading VC firms including Softbank, General Atlantic, Draper Fisher, BEV Capital and Goldman Sachs, and have been acquired by Continuus Software (NASD: CNSW), PiperJaffrey (NYSE: PJC) and SaveTree, LLC. Trevor is an annoyingly big fan of the Boston Red Sox and also loves fly-fishing for trout, the Black Crowes and the Rolling Stones (which he plays too frequently during his shifts as Office DJ). He graduated from the University of Pennsylvania where he would stand absolutely no chance of being admitted today. He is a committed soccer and little league coach, teacher of swimming, skiing, bike riding, skating, reading, drawing and all other activities pursued by his three young children Charlie, Tess and Catie. Trevor, his inordinately patient and wonderful wife Megan, their kids and two golden retrievers (Oxeon employees 5 & 6) live in the Tribeca neighborhood of New York City.

Laura Adams is the President and CEO of the Rhode Island Quality Institute (RIQI), a center of collaborative innovation that advances health and healthcare transformation. RIQI is the only organization in the nation to win all three of the major HITECH health IT grants which funded CurrentCare (the statewide health information exchange), the RI Regional Extension Center and the RI Beacon Community, bringing in $27M in funding. She was recently appointed to the Governor's Workgroup on Healthcare Innovation.Laura served on the ONC's HIT Policy Committee's Governance Panel for the Nationwide Health Information Network. She is a member of the Health Information Management and Systems Society (HIMSS) Center for Patient and Family Centered Care Advisory Group and chaired the Institute of Medicine's (IOM) Planning Committee for the "Digital Infrastructure for Population Health and a Learning Healthcare System" workshop series.Laura led the governance consulting for the Improving Performance in Practice (IPIP) Initiative, a RWJF-funded collaboration among the American Board of Medical Specialties, and the Boards and Societies of Internal Medicine, Family Physicians and Pediatrics. She traveled in the U.S. and Europe with W. Edwards Deming in the study of statistical-based quality improvement. She was Founder, President and CEO of Decision Support Systems, a New York-based company specializing in Internet-based healthcare decision support.Laura has been a faculty member of the Institute for Healthcare Improvement (IHI) in Boston since its inception. She directed the IHI Idealized Design of the Intensive Care Unit project and served as faculty in the VHA's ICU improvement collaborative. She was among the first to bring the principles of healthcare QI to the Middle East, in conjunction with Donald Berwick, MD and the Harvard Institute for Social and Economic Policy in the Middle East. She served as IHI faculty at the inaugural IHI Middle East Forum on Quality Improvement in Healthcare in Doha, Qatar in 2013. You can find out more at www.RIQI.org or by emailing Laura directly at LAdams@RIQI.org.

Kyle is the founder and CEO of PatientCrossroads, a provider of patient registry solutions to the rare and neglected disease community. PatientCrossroads collects patient provided medical history and testing results in order to gain insight into disease progression and to recruit patients for inclusion in clinical studies and trials. Kyle is a respected authority on rare disease patient registries and is a frequent speaker at research conferences educating the non-profit and research community on the need for universally accessible, de-identified patient information. Kyle's passion is to change the economics of patient provided information from closed, proprietary access, to universally available self-funding programs that accelerate disease research. You can find out more information at PatientCrossRoads.com.

Brian Gale, MBA MD, is a New York City radiologist. He has authored several papers and presentations on Critical Test Results Management (CTRM) systems. He founded SaferMD to reduce the risks of to diagnostic test results communications failure. He has developed a system to confirm that such test result notification programs are used effectively. Dr. Gale graduated from Columbia Business School and SUNY Buffalo School of Medicine. He is a past president of the Brooklyn Radiological Society. Contacts:Email: brian.gale@safermd.comWebsite: www.safermd.com Facebook: SaferMD Twitter: @SaferMD

Chris Bloomer is the leader of Trexin's healthcare capability. He is a business operations and IT leader with over 20 years of experience, exhibiting a strong track record of defining and executing transformational initiatives for industry-leading organizations. He has deep industry expertise in healthcare (payer and provider) and financial services. Chris' healthcare experience includes leading one of the nation's largest payers in the creation & delivery of their Affordable Care Act financial information management strategy. Previously, Chris served as Divisional CIO and VP of Client Integration at Accretive Health. He partnered with leading health care systems to create an innovative care model driving improved patient satisfaction, lower cost, and higher quality in Commercial and Pioneer ACOs environments. As COO & CIO at Dean Health Plan, he led a turnaround of the Information Technology organization. As the VP of Customer Service and IT at Blue Cross Blue Shield of MN, he was responsible for the overall Integrated Service Experience. Email: chris.bloomer@trexin.com LinkedIn: http://www.linkedin.com/in/chrisbloomer You can find out more at www.trexin.com.

Stacey Richter is not only the host of this podcast, but also the founder and strategic force behind Franklyn Healthcom, a pharmaceutical marketing and design agency that develops brand and managed market strategies along with digital and print collateral. Stacey began the business in 1993 with one simple idea: bridge the gap between current pharmaceutical agency practices and strategic business process. Her role on teams is often to transform customer insights and market research into cutting-edge strategies designed to drive access and provider uptake. As a successful marketer with a degree from the University of Pennsylvania, where she graduated magna cum laude, Stacey is uniquely positioned to convert managed markets theory into reality. Under her leadership, Franklyn Healthcom has developed an enduring reputation for needle-sharp innovations and original ideas that challenge the status quo. 00:00 Four Ways To Deal With Overwhelming Options 00:45 The different options for solving medication adherence problems. 01:50 The different options for solving medical treatment adherence issues. 03:40 Stacey's tips for managing and navigating the overwhelming choices for healthcare solutions. 08:10 "Most people don't succeed because of the fear of failure, not actual failure." 08:40 "We must make an intelligent compromise with perfection." 09:30 Find your "MVP": Minimal Viable Product. 13:00 Jumping into the unknown with "fuzzy goals". 15:30 1) Get Comfortable Getting Uncomfortable; 2) Just Do It; 3) Find Your MVP; 4) Pick A Finish Line, Not A Finish Dot

Joshua Benner, PharmD, ScD, is the Founder of RxAnte, a provider of science-based information technology solutions for improving quality and lowering the cost of healthcare. In August 2014, Dr. Benner was named the Executive Vice President of Strategy and Corporate Development for RxAnte's parent company, Millennium Health. A leading voice on medication adherence, Dr. Benner's award-winning research and numerous publications have shed new light on the problem of nonadherence and identified promising approaches to improving it. Prior to RxAnte, Dr. Benner was Fellow and Managing Director at the Brookings Institution's Engelberg Center for Health Care Reform, where he focused on medical technology policy. Prior to Brookings, Dr. Benner was principal at ValueMedics Research, an analytic and consulting services firm. Following the successful sale of ValueMedics to IMS Health in 2007, he served as senior principal in health economics and outcomes research and global lead for medication adherence at IMS. Dr. Benner received his Doctor of Pharmacy degree from Drake University and his Doctor of Science in health policy and management from the Harvard University School of Public Health. He remains a Visiting Scholar in Economic Studies at Brookings, and is an adjunct scholar in Clinical Epidemiology and Biostatistics at the University of Pennsylvania School of Medicine. Social Handles: LinkedIn: https://www.linkedin.com/company/rxante-inc- Twitter: https://twitter.com/rxante Facebook: https://www.facebook.com/RxAnte You can find out more information at www.RxAnte.com.

John R. Seitz is UST Global's Healthcare Transformation Strategist. As Healthcare Transformation Strategist, John Seitz plays a key role in building and developing value-focused relationships in health care. He is a high-energy leader with an entrepreneurial perspective that allows him to identify opportunities and to deliver results. John's skills include strategic planning, effective communication, problem solving and the ability to motivate people. For over twenty-five years, John has focused in the healthcare industry, earning the respect of both physicians and industry executives. Prior to UST, John has been a founder and either the CEO or President of three successful start-up companies in the healthcare industry. Most recently, John was the CEO and one of the founders of MMX Healthcare, which develops and deploys cloud-based solutions to the Ambulatory Surgical Center market. Prior to MMX, John held the position of President at Surgem, LLC (NJ) and was responsible for building this ASC Company from start-up to success ($0 in revenue to a run-rate in excess of $50M consolidated) in less than three years. You can find out more information at UST-Global.com and connect with John Seitz on LinkedIn.

TJ is a designer at heart and a pharmacist by training. He started his career at his family's long-term care pharmacy in 2004, and has worked at Target pharmacy, a local community pharmacy, and Massive Health (acquired by Jawbone). He holds a Doctor of Pharmacy (PharmD) degree from Massachusetts College of Pharmacy and Health Sciences. In 2015, Forbes named TJ to its 30 under 30 List in Healthcare. Interested providers may reach out to TJ directly at tj@pillpack.com, and patients and providers may both go to www.pillpack.com for more information.